Express
US Pharma Collabs to Submit MediLedger to DSCSA Proposing Blockchain for US Prescription Drugs
Summary: The US Food and Drug Administration started to accept project proposals to meet the Drug Supply Chain and Security Act (DSCSA) requirements for 2023. Of these projects, the FDA approved MediLedger Project. MediLedger is a group of 24 pharmaceutical manufacturers involved in logistics, retail chains, distributors, and solution providers, reports PR Newswire. The groups aim ...
The US Food and Drug Administration started to accept project proposals to meet the Drug Supply Chain and Security Act (DSCSA) requirements for 2023. Of these projects, the FDA approved MediLedger Project. MediLedger is a group of 24 pharmaceutical manufacturers involved in logistics, retail chains, distributors, and solution providers, reports PR Newswire.
The groups aim to look through blockchain technology to follow prescription medicines in the United States. The MediLedger DSCSA Pilot Project Final Report shows that blockchain performance can reach the future requirements of the 2023 DSCSA. Matt Sample, Vice President of Manufacturing Operations and AmerisourceBergen, expressed that whether or not blockchain technology will be a part of the 2023 landscape, there is hope that blockchain in the industries can learn from the evaluated cases.
By Claudia Rivera
Tags: Blockchain,DSCSA,FDA,MediLedger,pharmaceutical
Link: US Pharma Collabs to Submit MediLedger to DSCSA Proposing Blockchain for US Prescription Drugs [Copy]
